课题基金 / 基金详情

Molecular basis of defective CD8 T cells during chronic viral infection

Molecular basis of defective CD8 T cells during chronic viral infection
慢性病毒感染期间缺陷型 CD8 T 细胞的分子基础
批准号:
7522985
负责人:
Hao Shen
金额:
$19.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-08 至 2011-04-30

项目摘要

项目成果

Hao Shen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): CD8 T cells play an important role in the clearance of many viral infections and in providing protective immunity against re-infection. In assessing the effectiveness of the CD8 T cell response, most studies have focused on correlating the magnitudes of the response with the level of protection it provides. However, recent studies have shown that effective control of viral infection is dependent on not only the quantity but also the quality of antigen-specific CD8 T cells. Using infection of mice with lymphocytic choriomeningitis virus (LCMV) as a model, we have discovered that memory CD8 T cells generated in the absence of CD4 T cell help are of poor quality. These "unhelped" memory CD8 T cells have a decreased ability to persist, produce low levels of effector cytokines following restimulation, and most significantly, do not provide adequate protection against secondary challenge. This loss of functionality in CD8 T cells is also observed during chronic LCMV infection and is thought to contribute to the failure of the host to clear the infection. Our recent studies have been focused on elucidating the mechanisms behind why "unhelped" CD8 T cells are unable to function properly. We have shown that defects in "unhelped" memory CD8 T cells are not due to aberrations in the TCR repertoire nor to impairment in functional avidity maturation. Instead, our results show that the defect lies downstream of TCR signaling and is due to a failure of these cells to undergo specific epigenetic modifications at several loci critical for effector functions. We will test the hypothesis that a failure of CD8 T cells to undergo requisite epigenetic modifications contributes to their inability to function properly during chronic LCMV infection. More specifically, in Aim 1 we will determine if differences in epigenetic remodeling contribute to the inability of antigen-specific CD8 T cells to function properly during chronic infection. In Aim 2, we will examine if the defective CD8 T cells that arise during chronic infection can be reprogrammed through epigenetic modification to gain full functionality. The results of these studies may help us develop new strategies that will improve the functionality of CD8 T cells and thus enhance immune control of viral infection. PUBLIC HEALTH RELEVANCE Clearance of many viral infections is critically dependent on the function of CD8 T cells. Recent results have shown that CD8 T cells become functionally defective when CD4 T cell help is absent. This loss of functionality in CD8 T cells is also observed during chronic viral infection and is thought to contribute to the failure of the host to clear the infection. In this study, we aim to understand why CD8 T cells become defective during chronic viral infection and in the absence of CD4 T cells help. In doing so, we hope to develop new strategies that will enhance the functionality of CD8 T cells and thus immune control of viral infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regenerative therapy for lung infection by S. pneumoniae
  • 批准号:
    9388099
  • 项目类别:
  • 资助金额:
    $25.58万
  • 财政年份:
    2017
  • 负责人:
    Hao Shen
  • 依托单位:
Treating chronic viral infection by epigenetic reprogramming of exhausted CD8 T cells
  • 批准号:
    9768950
  • 项目类别:
  • 资助金额:
    $54.56万
  • 财政年份:
    2017
  • 负责人:
    Hao Shen
  • 依托单位:
Microbiology Core
  • 批准号:
    8089288
  • 项目类别:
  • 资助金额:
    $17.26万
  • 财政年份:
    2010
  • 负责人:
    Hao Shen
  • 依托单位:
The Impact of Bacterial Co-Infectin on Respiratory Virus-Specific T cell Response
  • 批准号:
    8089283
  • 项目类别:
  • 资助金额:
    $33.43万
  • 财政年份:
    2010
  • 负责人:
    Hao Shen
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究